ThromboGenics (THR) - BEL20
2 mensagens
|Página 1 de 1
ThromboGenics (THR) - BEL20
A ThromboGenics passará a estar incluída no BEL20, a partir de 18 de Março.
Sector
Healthcare
Biotechnology / Pharmaceuticals
Biotechnology / Pharmaceuticals
Biotechnology
Business Summary
ThromboGenics specializes in the research and development of bio-therapeutic products for treating cardiovascular diseases, ophthalmic disorders, and cancers. Net sales break down by source of income as follows:
- sales of licenses (96.9%);
- royalties (1.8%);
- other (1.3%).
4-traders.com
Editado pela última vez por C0rr3i4 em 19/2/2013 19:53, num total de 2 vezes.
C0rr3i4
"Compound interest is the 8th wonder of the world."
(Albert Einstein)
"Compound interest is the 8th wonder of the world."
(Albert Einstein)
-
- Mensagens: 1561
- Registado: 18/1/2012 17:35
- Localização: Sorria, está na Maia.
2 mensagens
|Página 1 de 1
Quem está ligado:
Utilizadores a ver este Fórum: Akinfiev, carlosdsousa, Ferreiratrade, Google [Bot], Google Adsense [Bot], Goya777, jprgodinho, Kury Yozo, m-m, malakas, Mr.Warrior, MR32, nunorpsilva, O Magriço, OCTAMA, OffTheRecord, PAULOJOAO, Phil2014, Purificaçao, SerCyc, Shimazaki_2, Simplório, smog63, tami e 146 visitantes